Open | 0.72 |
Previous Close | 0.77 |
Day Range | 0.68 - 0.74 |
52-Week Range | 0.68 - 7.34 |
All-Time High | 121.16 |
Avg. Volume (50-day) | 2,205,471 |
EPS (TTM) | -1.6495 |
Next Earnings Date | 2025-05-15 (AMC) |
Last Earnings Date | 2025-03-05 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.4700 |
PEG Ratio | - |
Price to Book | 0.28 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 13.63 M |
Revenue per Share (TTM) | 0.12 |
Shares Outstanding | 114.597 M |
Share Float (%) | 103.48 M |
% Held by Institutions | 84.93 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.9 (-24.44%) |
+/- SMA(50) | 1.13 (-39.82%) |
+/- SMA(200) | 2.59 (-73.75%) |
5-Day Perf. | -22.87% |
1-Month Perf. | -33.98% |
3-Month Perf. | -62.22% |
6-Month Perf. | -78.21% |
YTD Perf. | -58.79% |
1-Year Perf. | -90.3% |
RSI(14) | 28.76 |
ATR(14) | 0.09 |
ADX(14) | 23.93 |
Beta (5Y) | 1.73 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
FATE has triggered the following predefined scans:
P&F Double Bottom Breakdown |
Moved Below Lower Bollinger Band |
Moved Below Lower Price Channel |
P&F Bearish Triangle |
New 52-week Lows |
Moved Below Lower Keltner Channel |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.